Shlomo Noy serves as Executive at Silexion Therapeutics Corp, where they oversee executive responsibilities. Since joining the company, Shlomo Noy has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved receiving (via award) 10,685 shares valued at $0.
Shlomo Noy currently holds 10,685 shares of Silexion Therapeutics Corp (SLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shlomo Noy has been a net neutral trader of SLXN stock. They have purchased $0 and sold $0 worth of shares.
Shlomo Noy's most recent insider trade was on Feb 20, 2026, when they sold 10,685 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 9, 2025 | SLXN | $0 | Award | 1,587 | $N/A | Discretionary |